Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
670.4 INR | +1.32% | -2.52% | -4.95% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With an expected P/E ratio at 39.81 and 25.09 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.95% | 256M | - | ||
-18.17% | 8.55B | B+ | ||
+87.40% | 4.63B | C+ | ||
+16.31% | 2.98B | B- | ||
-3.15% | 2.65B | - | ||
-2.10% | 1.89B | C- | ||
-53.27% | 1.81B | B- | ||
-12.97% | 1.56B | A- | ||
+21.59% | 1.27B | B+ | ||
-47.96% | 1.07B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- KRSNAA Stock
- KRSNAA Stock
- Ratings Krsnaa Diagnostics Limited